$208.43
1.83 (-0.87%)
Last updated: Apr 16, 2026 00:50
Fundamentals Overview
AbbVie Inc. is in the middle of its 52-week range with premium valuation, trading relatively flat today.
Valuation premium
Intrinsic value (DCF)
-21.9% downside vs price
Profitability
Risk (Beta)
0.36 — lower vol
Earnings & growth
BullzEye Analysis
Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.
Composite Signal
Pressures (Sell):
DCF 21.9% downside vs price · 3M vs S&P 500: -6%
Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.
Key Stats
About
Ratings & Grades at a Glance
Overall rating: C+. Recent institutional grades: mixed. Current institutional positions: Buy: 6, Hold: 1, Neutral: 5, Outperform: 5, Overweight: 12, Peer Perform: 1.
Valuation & Ratios
Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.
DCF vs price: DCF estimate is $162.77; current price is $208.43. That’s a -21.9% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.
| Metric | Value |
|---|---|
| Valuation | |
| P/E (TTM) | 87.5 |
| DCF value (model) | $162.77 (-21.9% vs price) |
| PEG (TTM) | N/A |
| P/B (TTM) | N/A |
| P/S (TTM) | 6.03 |
| P/FCF (TTM) | 19.71 |
| Liquidity & enterprise | |
| Current Ratio (TTM) | 0.67 |
| Quick Ratio (TTM) | 0.56 |
| Cash Ratio (TTM) | 0.12 |
| Profitability | |
| ROE (TTM) | N/A |
| ROA (TTM) | N/A |
| Revenue growth (YoY) | N/A |
| Net margin (TTM) | 6.91% |
| Gross margin (TTM) | 73.34% |
| Operating margin (TTM) | 26.72% |
| Debt to equity (TTM) | N/A |
Latest News
News loads when you open this tab.
Price Target, Ratings & Grades
Analyst price targets, consensus, rating snapshot, and institutional grades for ABBV.
Analyst Sentiment at a Glance
Stock Grades (Institutions)
| Institution | Action | Previous Grade | New Grade | Date |
|---|---|---|---|---|
| Guggenheim | maintain | Buy | Buy | 2026-04-10 |
| Cantor Fitzgerald | maintain | Overweight | Overweight | 2026-04-08 |
| Piper Sandler | maintain | Overweight | Overweight | 2026-02-18 |
| Freedom Broker | maintain | Buy | Buy | 2026-02-17 |
| Evercore ISI Group | maintain | Outperform | Outperform | 2026-02-05 |
| UBS | maintain | Neutral | Neutral | 2026-02-05 |
| Morgan Stanley | maintain | Overweight | Overweight | 2026-02-05 |
| Citigroup | maintain | Neutral | Neutral | 2026-01-27 |
| Wolfe Research | downgrade | Outperform | Peer Perform | 2026-01-08 |
| Morgan Stanley | maintain | Overweight | Overweight | 2025-12-12 |
| HSBC | upgrade | Hold | Buy | 2025-12-10 |
| Freedom Broker | maintain | Buy | Buy | 2025-11-12 |
| UBS | maintain | Neutral | Neutral | 2025-11-07 |
| Piper Sandler | maintain | Overweight | Overweight | 2025-11-05 |
| Citigroup | maintain | Neutral | Neutral | 2025-11-03 |
| JP Morgan | maintain | Overweight | Overweight | 2025-11-03 |
| Guggenheim | maintain | Buy | Buy | 2025-10-20 |
| Raymond James | maintain | Outperform | Outperform | 2025-10-17 |
| Piper Sandler | maintain | Overweight | Overweight | 2025-10-10 |
| Cantor Fitzgerald | maintain | Overweight | Overweight | 2025-10-09 |
| B of A Securities | maintain | Neutral | Neutral | 2025-10-03 |
| HSBC | downgrade | Buy | Hold | 2025-10-01 |
| Evercore ISI Group | maintain | Outperform | Outperform | 2025-09-22 |
| Berenberg | upgrade | Hold | Buy | 2025-09-17 |
| JP Morgan | maintain | Overweight | Overweight | 2025-09-16 |
| Cantor Fitzgerald | maintain | Overweight | Overweight | 2025-09-15 |
| Wells Fargo | maintain | Overweight | Overweight | 2025-09-12 |
| BMO Capital | maintain | Outperform | Outperform | 2025-09-12 |
| Cantor Fitzgerald | maintain | Overweight | Overweight | 2025-08-13 |
| Evercore ISI Group | maintain | Outperform | Outperform | 2025-08-01 |